374 related articles for article (PubMed ID: 15525529)
1. The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF.
Hamada F; Bienz M
Dev Cell; 2004 Nov; 7(5):677-85. PubMed ID: 15525529
[TBL] [Abstract][Full Text] [Related]
2. C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila.
Fang M; Li J; Blauwkamp T; Bhambhani C; Campbell N; Cadigan KM
EMBO J; 2006 Jun; 25(12):2735-45. PubMed ID: 16710294
[TBL] [Abstract][Full Text] [Related]
3. The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.
Sierra J; Yoshida T; Joazeiro CA; Jones KA
Genes Dev; 2006 Mar; 20(5):586-600. PubMed ID: 16510874
[TBL] [Abstract][Full Text] [Related]
4. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.
Valenta T; Lukas J; Korinek V
Nucleic Acids Res; 2003 May; 31(9):2369-80. PubMed ID: 12711682
[TBL] [Abstract][Full Text] [Related]
5. APC 3 x 15 beta-catenin-binding domain potentiates beta-catenin association to TBP and upregulates TCF-4 transcriptional activity.
Roura S; Martínez D; Piedra J; Miravet S; García de Herreros A; Duñach M
Biochem Biophys Res Commun; 2003 Oct; 309(4):830-5. PubMed ID: 13679048
[TBL] [Abstract][Full Text] [Related]
6. TCF transcription factors: molecular switches in carcinogenesis.
Roose J; Clevers H
Biochim Biophys Acta; 1999 Oct; 1424(2-3):M23-37. PubMed ID: 10528152
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a beta-catenin/APC complex reveals a critical role for APC phosphorylation in APC function.
Xing Y; Clements WK; Le Trong I; Hinds TR; Stenkamp R; Kimelman D; Xu W
Mol Cell; 2004 Aug; 15(4):523-33. PubMed ID: 15327769
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
9. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
10. APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC.
Schneikert J; Brauburger K; Behrens J
Hum Mol Genet; 2011 Sep; 20(18):3554-64. PubMed ID: 21665989
[TBL] [Abstract][Full Text] [Related]
11. Hot spots in beta-catenin for interactions with LEF-1, conductin and APC.
von Kries JP; Winbeck G; Asbrand C; Schwarz-Romond T; Sochnikova N; Dell'Oro A; Behrens J; Birchmeier W
Nat Struct Biol; 2000 Sep; 7(9):800-7. PubMed ID: 10966653
[TBL] [Abstract][Full Text] [Related]
12. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
13. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
[TBL] [Abstract][Full Text] [Related]
14. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
15. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
Henderson BR; Galea M; Schuechner S; Leung L
J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
[TBL] [Abstract][Full Text] [Related]
16. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
[TBL] [Abstract][Full Text] [Related]
17. Differences between the interaction of beta-catenin with non-phosphorylated and single-mimicked phosphorylated 20-amino acid residue repeats of the APC protein.
Tickenbrock L; Kössmeier K; Rehmann H; Herrmann C; Müller O
J Mol Biol; 2003 Mar; 327(2):359-67. PubMed ID: 12628243
[TBL] [Abstract][Full Text] [Related]
18. Identification of Tcf4 residues involved in high-affinity beta-catenin binding.
Omer CA; Miller PJ; Diehl RE; Kral AM
Biochem Biophys Res Commun; 1999 Mar; 256(3):584-90. PubMed ID: 10080941
[TBL] [Abstract][Full Text] [Related]
19. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
[TBL] [Abstract][Full Text] [Related]
20. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
